Sugi Predict

Sugi Predict / Compounds / SCHEMBL789772

SCHEMBL789772

SCHEMBL789772

CC(=O)Oc1ccccc1C(=O)OC(=O)c1ccccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 6/20 0.61
▸ KDM4E B2RXH2 4/20 0.61
▸ LMNA P02545 2/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ HPGD P15428 5/20 0.59
▸ PTGS2 P35354 5/20 0.59
▸ ALDH1A1 P00352 3/20 0.59
▸ ESR1 P03372 3/20 0.59
▸ TSHR P16473 2/20 0.59
▸ TDP1 Q9NUW8 2/20 0.59
▸ ITGB3 P05106 1/20 0.59
▸ ITGA2B P08514 1/20 0.59
▸ HMGB1 P09429 1/20 0.59
▸ GGT1 P19440 1/20 0.59
▸ PTGS1 P23219 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ NAPRT Q6XQN6 1/20 0.59
▸ ALOX15 P16050 1/20 0.50
▸ KMT2A Q03164 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL789771 0.91 HSD17B10 (0.71) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL29669847 0.91 HSD17B10 (0.71) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL15543333 0.89 HSD17B10 (0.66) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL14972 0.86 HSD17B10 (0.69) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL2338852 0.85 HSD17B10 (0.63) HSD17B10KDM4ELMNACYP1A2CYP2C9
Benzoic Acid SCHEMBL8118213 0.84 HSD17B10 (0.67) HSD17B10KDM4ELMNACYP1A2CYP2C9
Salsalate SCHEMBL17422748 0.84 KDM4E (0.84) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL2337247 0.83 KDM4E (0.66) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL13579096 0.83 HSD17B10 (0.54) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL11689807 0.83 KDM4E (0.62) HSD17B10KDM4ELMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118065203-B High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-07-23 — — CN claimed
CN-118065203-A High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-05-24 — — CN claimed
CN-113861096-B Indole structure-containing compound, preparation method and application thereof 中国农业大学 2023-07-18 — — CN claimed
CN-115448911-A Preparation method of posaconazole intermediate 成都海博为药业有限公司 2022-12-09 — — CN claimed
WO-2022228297-A1 ENZYMATIC PREPARATION TECHNIQUE FOR ACYL/AROYL COENZYME A 中国医学科学院药物研究所 2022-11-03 — — WO claimed
CN-115247192-A Enzymatic preparation technology of acyl/aroyl coenzyme A 中国医学科学院药物研究所 2022-10-28 — — CN claimed
CN-113861096-A Compound containing indole structure, preparation method and application thereof 中国农业大学 2021-12-31 — — CN claimed
CN-109513427-A A kind of preparation method of straw base chromium ion adsorbent 浙江海洋大学 2019-03-26 — — CN claimed
US-9644074-B2 Benzene polycarboxylic acid compounds and their use as drug RINNOVATION APS (DK) 2017-05-09 — — US claimed
EP-2831151-B1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDINNOVATION APS (DK) 2016-12-14 — — EP claimed
US-20160017104-A1 Benzene Polycarboxylic Acid Compounds and Their Use as Drug RDINNOVATION APS (DK) 2016-01-21 — — US claimed
EP-2831151-A1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDInnovation ApS (DK) 2015-02-04 — — EP claimed
WO-2013143549-A1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDINNOVATION APS (DK) 2013-10-03 — — WO claimed
WO-2008037366-A2 SOLID STATE FORMS AB OF ACETYL SALICYLIC ACID SCICONCEPT GMBH (DE) 2008-04-03 — — WO claimed
CN-122042851-A Liquid chromatography method for determining aspirin content in calcium chloride-based cabapilin calcium mother liquor 山东青科农牧发展有限公司 2026-05-15 — — CN disclosed
CN-115448911-B Posaconazole intermediate Process for the preparation of intermediates 成都海博为药业有限公司 2024-08-16 — — CN disclosed
CN-118065203-B High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-07-23 — — CN disclosed
US-4563443-A ANTIPYRETIC, MUCOLYTIC EDMOND PHARMA S.R.L. (IT) 1986-01-07 — — US disclosed
EP-0103320-A2 Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them Edmond Pharma Srl (IT) 1984-03-21 — — EP disclosed
US-4420482-A ANTITISTAMINES, ANALGESICS SELVI & C. S.P.A. (IT) 1983-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160017104-A1 Benzene Polycarboxylic Acid Compounds and Their Use as Drug PAH, HPD, PLOD2 HSD17B10 185/4885KDM4E 561/4885LMNA 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.